Inactivating CUX1 mutations promote tumorigenesis.

Saved in:
Bibliographic Details
Title: Inactivating CUX1 mutations promote tumorigenesis.
Authors: Wong CC; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK., Martincorena I; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Rust AG; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Rashid M; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Alifrangis C; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Alexandrov LB; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Tiffen JC; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Kober C; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2]., Green AR; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Massie CE; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Nangalia J; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Lempidaki S; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Bray SJ; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., McDermott U; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Papaemmanuil E; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Campbell PJ; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Adams DJ; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Corporate Authors: Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
Source: Nature genetics [Nat Genet] 2014 Jan; Vol. 46 (1), pp. 33-8. Date of Electronic Publication: 2013 Dec 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-1718
DOI:10.1038/ng.2846